Increased adherence has proven large cost savings for clinical trials, by reducing the amount of patients needed to reach reliable results.

Table showing average savings in clinical trails with 1% increased adherence. 

...at 39%

​

Average cost savings per 1% improvement in IMP adherence

Estimated wasted capital on cost of enrolling additional patients at 40% non-adherence

...at 39%

​

Estimated additional patients needed to maintain statistical power at 40% non-adherence

Trial phase

​

$ 19,036

​

$ 50,904

​

$ 335,725

​

$ 167,050

$ 655,475

​

$ 2,171,250 

​

$ 11,960,000

​

$ 6,093,750

41

​

110

​

447

​

228

42

​

113

​

460

​

234

Phase I 

Phase II  

​

Phase III

​

Phase IV

$ 636,439

​

$ 2,120,346

​

$ 11,624,275

​

$ 5,926,700

Our adherence solutions support patients in managing their medical treatment and provides real-time data of their adherence. The solutions can be adapted to your needs and IT-system. 

​

Want to find out more? 

...or let us send an email to you. *no spam guarantee